HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Clinical trials for HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to stop myeloma return after transplant
Disease control OngoingThis study tests whether adding elotuzumab to standard lenalidomide maintenance therapy can help keep multiple myeloma from returning after a stem cell transplant. About 113 adults who had a transplant using their own stem cells will receive the drug combination. The goal is to s…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:53 UTC
-
New combo before transplant aims to beat High-Risk leukemia
Disease control TerminatedThis study is for people with high-risk acute leukemia or myelodysplastic syndrome (MDS). It tests a new way to prepare the body for a donor stem cell transplant by combining targeted radiation (TMLI) with two chemotherapy drugs. The goal is to find the safest dose that can kill …
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 08:27 UTC
-
Childhood cancer survivors monitored for decades to uncover late effects
Knowledge-focused OngoingThis study follows up to 5,000 children and teens who have had cancer or a stem cell transplant. Researchers collect health information over many years to learn about long-term side effects of treatment. The goal is to reduce future health problems and improve quality of life for…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 26, 2026 08:40 UTC